Publicacións (268) Publicacións nas que participase algún/ha investigador/a Ver datos de investigación referenciados.

2024

  1. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  3. Copper Overload Increased Rat Striatal Levels of Both Dopamine and Its Main Metabolite Homovanillic Acid in Extracellular Fluid

    International Journal of Molecular Sciences, Vol. 25, Núm. 15

  4. Correction to: Pharmacological Modulators of Tau Aggregation and Spreading (Brain Sciences, (2020), 10, 11, (858), 10.3390/brainsci10110858)

    Brain Sciences

  5. Dissecting the Effects of Cephenemyia stimulator on the Olfactory Turbinates and Nasopharynx of Roe Deers (Capreolus capreolus)

    Animals, Vol. 14, Núm. 9

  6. Do fossorial water voles have a functional vomeronasal organ? A histological and immunohistochemical study

    Anatomical Record, Vol. 307, Núm. 8, pp. 2912-2932

  7. First Immunohistochemical Demonstration of the Expression of a Type-2 Vomeronasal Receptor, V2R2, in Wild Canids

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  8. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

    Molecular Metabolism, Vol. 79

  9. Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain

    Neuropathology and Applied Neurobiology, Vol. 50, Núm. 1

  10. Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity

    Journal of Controlled Release, Vol. 372, pp. 295-303

  11. Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia

    Mitochondrion, Vol. 78

  12. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models

    Stem Cell Research and Therapy, Vol. 15, Núm. 1

  13. Possible vascular complications due to anatomical variations in dental surgical treatments

    European Journal of Anatomy, Vol. 28, Núm. 2, pp. 207-213

  14. The role of the brain renin-angiotensin system in Parkinson´s disease

    Translational Neurodegeneration, Vol. 13, Núm. 1

  15. The vomeronasal system of the wolf (Canis lupus signatus): The singularities of a wild canid

    Journal of Anatomy, Vol. 245, Núm. 1, pp. 109-136

2023

  1. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 110

  2. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

    Brain, Behavior, and Immunity, Vol. 108, pp. 255-268

  3. Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner

    Nature Communications, Vol. 14, Núm. 1

  4. Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease

    Neurobiology of Disease, Vol. 188

  5. Combined cell-based therapy strategies for the treatment of Parkinson's disease: Focus on mesenchymal stromal cells

    Neural Regeneration Research, Vol. 18, Núm. 3, pp. 478-484